One major claim can change the financial picture of an employer-sponsored health plan remarkably quickly.
A complex cancer diagnosis, organ transplant, premature birth, specialty medication or extended hospital stay can generate hundreds of thousands of dollars in claims. Some newer cell and gene therapies can push costs even higher.
Employers cannot predict who will develop a serious illness, nor should cost management ever interfere with an employee receiving appropriate care. But that does not mean organizations have to wait for a large claim to arrive before thinking about its financial impact.
High-cost claims require a different kind of planning. The goal is not to eliminate risk. It is to understand where that risk may be developing, put appropriate protections in place and make sure employees have access to high-quality, cost-effective care when they need it most.
High-Cost Claims Are Becoming Harder to Treat as Outliers
Every health plan has claim volatility. Historically, an employer might experience an unusually expensive year followed by a return to more predictable utilization.
Today’s environment is more complicated.
Cancer treatment continues to be a significant source of employer healthcare spending. Business Group on Health reports that cancer remains the top condition driving employer healthcare costs, while employers are also facing increasing costs associated with specialty medications and advanced therapies.
At the same time, medical innovation is producing remarkable treatments for conditions that previously had limited options. That is very good news for patients, but many of these therapies arrive with substantial price tags.
For employers, high-cost claims are no longer something to review only after the plan year ends. They have become an important part of ongoing benefits strategy.
Start With Better Visibility Into Claims
Employers cannot manage what they cannot see.
Claims reporting should provide more than a monthly total. Employers and their benefits advisors should be able to identify emerging high-cost claimants, recurring conditions, specialty pharmacy utilization, hospital patterns and other changes that could affect future spending.
That does not mean attempting to predict individual medical outcomes. It means recognizing financial patterns early enough to evaluate available options.
For example, an employee undergoing ongoing oncology treatment may continue generating significant claims well into the next plan year. A new specialty medication may become a recurring expense rather than a one-time claim. Several smaller claims involving the same chronic condition may point toward a growing population-level cost driver.
Regular analysis turns those events from renewal-season surprises into information employers can use for planning.
MSI explores this in greater detail in Unlocking the Power of Claims Data: Your Underused Asset in Cost Control.
Look Beyond the Price of Specialty Medications
Specialty pharmacy deserves particular attention because an expensive prescription is often only one piece of the cost equation.
Employers should evaluate whether medications are being obtained through the most appropriate channel, whether clinical management programs are in place and whether lower-cost therapeutic or biosimilar alternatives are available when medically appropriate.
Site of care can also matter.
Some infused medications may be administered in a hospital outpatient setting at a substantially different cost than the same therapy delivered through another clinically appropriate setting. Identifying those differences can create meaningful savings without changing the treatment itself.
Case management can play an equally valuable role. For an employee navigating cancer, a transplant or another serious diagnosis, the healthcare system can be extraordinarily complex. Coordinated case management may help connect the patient with appropriate specialists, manage treatment transitions, identify centers of excellence and reduce unnecessary duplication of services.
The strongest cost-management strategies often improve the employee’s experience at the same time they improve the plan’s financial performance.
Consider the Entire Episode of Care
A high-cost claim should rarely be examined as an isolated invoice.
Take cancer treatment as an example. The financial impact may include diagnostic imaging, surgery, hospital care, physician services, radiation, infused therapies, specialty prescriptions, laboratory services and follow-up care.
Looking only at one component can hide opportunities elsewhere in the treatment journey.
Employers may benefit from evaluating centers of excellence, specialty networks, care navigation programs and other solutions that help members reach providers with demonstrated expertise and strong outcomes.
Quality matters financially as well as clinically.
Complications, readmissions, inappropriate treatment and fragmented care can add significant expense to an already costly medical episode. Helping employees reach high-quality providers can therefore be both a benefits strategy and a cost-control strategy.
Don’t Forget the Connection to Stop-Loss Coverage
For self-funded employers, high-cost claim planning and stop-loss strategy should operate together.
Specific stop-loss coverage limits an employer’s exposure to exceptionally large claims involving an individual participant once claims exceed the plan’s individual specific limit, while aggregate coverage can provide protection when overall plan claims exceed expected levels.
But simply having stop-loss coverage does not eliminate financial risk.
Contract terms, reimbursement provisions, exclusions, claim reporting requirements and individual lasers can all affect how much exposure ultimately remains with the employer.
An emerging claimant can also influence the next stop-loss renewal. Understanding that exposure early gives employers and their advisors more time to analyze alternatives and prepare for negotiations.
For a deeper discussion of those issues, see Stop-Loss Insurance: What Self-Funded Employers Should Review Before Renewal.
Build High-Cost Claim Planning Into the Entire Year
One of the biggest mistakes employers can make is treating large claims as a renewal issue.
By the time renewal proposals arrive, much of the year’s claims experience has already occurred and options may be limited.
A more effective approach includes regular checkpoints throughout the year.
Claims and pharmacy reports can be reviewed for emerging trends. Large claimant activity can be compared with prior projections. Case management and navigation programs can be evaluated for effectiveness. Stop-loss exposure can be monitored. Specialty medication utilization can be reviewed before it becomes a major surprise.
This kind of oversight also creates a clearer picture for future budgeting.
A large claim may still occur unexpectedly. But there is a significant difference between experiencing an unexpected claim and being financially unprepared for the possibility of one.
📌 High-Cost Claim Planning: Key Strategies for Employers
Monitor emerging claims throughout the year. Look for developing cost patterns rather than waiting until renewal.
Evaluate specialty pharmacy carefully. Review clinical management, biosimilars, sourcing and site-of-care opportunities.
Focus on quality of care. Centers of excellence and specialized networks may improve outcomes while reducing avoidable costs.
Use case management strategically. Complex conditions often benefit from coordinated care and member navigation.
Review stop-loss protection early. Understand individual specific limits, lasers, exclusions and potential renewal exposure.
Connect claims analysis to budgeting. Use current utilization and emerging risks to improve forecasting.
Plan before the claim happens. Preparation creates more options than reaction.
Preparation Changes the Conversation
No benefits strategy can prevent every catastrophic medical event. Nor should an employer’s objective be to avoid paying for necessary care.
The opportunity is to make sure the health plan responds intelligently when expensive care is needed.
That means understanding claims as they develop, directing members toward high-quality resources, scrutinizing specialty pharmacy costs, coordinating complex care, maintaining appropriate financial protection and incorporating emerging risks into long-term planning.
High-cost claims will remain part of employer-sponsored healthcare. Financial surprises do not have to be.
Ready to Strengthen Your High-Cost Claim Strategy?
MSI Benefits Group helps employers use claims analytics, pharmacy strategies, plan design and ongoing financial monitoring to identify emerging risks and manage healthcare spending throughout the year.
If you would like to better understand where high-cost claim exposure may be developing within your benefits program, contact MSI Benefits Group. Our team can help you turn claims data into a proactive strategy for protecting both your employees and your benefits budget.